The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Fred Hutchinson Cancer Research Center competitive analysis

Loading summary...

Latest patents of Fred Hutchinson Cancer Research Center opposed by its competitors

Explore Fred Hutchinson Cancer Research Center's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP2884999
Oct 8, 2025Method And Compositions For Cellular Immunotherapy1
EP3824905
Jan 8, 2025Method And Compositions For Cellular Immunotherapy1
EP3688157
Apr 27, 2022High Efficiency Targeted In Situ Genome-Wide Profiling1
EP3636778
Jan 12, 2022Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd)2
EP3247808
May 5, 2021Point-Of-Care And/Or Portable Platform For Gene Therapy2
EP3363901
Dec 30, 2020Compositions And Methods For Accurately Identifying Mutations3
EP2689010
Nov 18, 2020Method And Compositions For Cellular Immunotherapy1
EP3192880
Oct 9, 2019Nucleic Acid Agents For Use In Treating Facioscapulohumeral Dystrophy (Fshd)2
EP2814959
Jan 17, 2018Compositions And Methods For Accurately Identifying Mutations1

Latest PTAB cases involving Fred Hutchinson Cancer Research Center

Discover the latest PTAB cases involving Fred Hutchinson Cancer Research Center, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Fred Hutchinson Cancer Research Center with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
FRED HUTCHINSON CANCER RESEARCH CENTER - 14 - -
JAMES POOLE153 - - -
KONIG SZYNKA TILMANN VON RENESSE34 - - -
STRAWMAN339 - - -